Global Selective Serotonin Reuptake Inhibitors Market - Industry Size, Share, Trends, Growth and Forecast 2016 - 2024
"The
Latest Research Selective Serotonin Reuptake Inhibitors Market -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast
2016 - 2024 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
Selective
Serotonin Reuptake Inhibitors Market: Overview
Selective
serotonin reuptake inhibitors (SSRIs) elevate the extracellular level
of neurotransmitters known as serotonin by inhibiting its uptake in
presynaptic cells. Therefore, selective serotonin reuptake inhibitors
are widely used as medication for the treatment of severe or
persistent depression. In addition, selective serotonin reuptake
inhibitors are also used in combination with therapies such as
cognitive behavioral therapy (CBT).
Furthermore,
selective serotonin reuptake inhibitors are also used for mental
conditions such as panic disorders, obsessive compulsive disorder
(OCD), post-traumatic stress disorder (PTSD), severe phobias,
including social phobia and agoraphobia, and generalized anxiety
disorder (GAD). In addition, selective serotonin reuptake inhibitors
are also used for the treatment of premenstrual syndrome, premature
ejaculation, irritable bowel syndrome and fibromyalgia. Side effects
of selective serotonin reuptake inhibitors include, low sex drive,
dizziness, sickness, anxiety, erectile dysfunction in male population
and blurred vision.
Get
Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1357480
Selective
Serotonin Reuptake Inhibitors Market: Growth Enablers
According
to the World Health Organization (WHO), depression is the fourth
leading cause of deaths and by 2020; it is expected to be the second
leading cause of deaths worldwide. According to the National
Institute of Mental Health (NIHM), part of National Institute of
Health (NIH) of the U.S., in 2012, around 16 million adults above 18
years of age had at least one major depressive episode in the past
year in the U.S. Risk of depression is twice in women population.
According
to the Depression and Bipolar Support Alliance, the lifetime
prevalence for female population is 20% to 26%. While life time
prevalence of depression for male population is 8% to 12%. According
to the article published by the British Psychology Society in June
2013, finding from the Office for National Statistics (ONS) states
that approximately one fifth of the overall adult population
experience depression. Thus, perpetually rising prevalence depression
worldwide is the major factor driving the growth of the global
selective serotonin reuptake inhibitors (SSRIs) market.
Selective
Serotonin Reuptake Inhibitors Market: Region-wise Insight
Geographically,
the selective serotonin reuptake inhibitors market is segmented into
North America, Europe, Asia Pacific and Rest of the World (RoW).
Presently, Europe and North America are dominating the global
selective serotonin reuptake inhibitors (SSRIs) market. Factors such
as, divorce, unemployment, work pressure, and higher life
expectations are resulting in higher rate of depression cases.
Furthermore,
availability of advanced healthcare facilities and higher healthcare
spending are driving the growth of selective serotonin reuptake
inhibitors market in Europe and North America. Asia Pacific is a
lucrative market for selective serotonin reuptake inhibitors (SSRIs).
Factors such as rapidly growing prevalence of depression and mental
conditions, rising awareness about depression and related treatments
available and rising healthcare expenditure are expected to drive the
selective serotonin reuptake inhibitors market in Asia Pacific
region.
View
Report @
https://www.marketresearchreports.biz/reports/1357480/selective-serotonin-reuptake-inhibitors-market-research-reports
Though,
prevalence rate of depression is high in Rest of the World (RoW),
lack of awareness about related treatment is limiting the growth of
the selective serotonin reuptake inhibitors market in this region.
Brazil and Argentina are expected to show faster growth rate than
other countries in Rest of the World owing to availability of well
defined regulatory framework and developed healthcare infrastructure.
African countries will experience slower growth rate in the forecast
period due to poorly developed healthcare infrastructure coupled with
lack of availability of regulatory framework.
Some
of the commercially available brands of SSRI include Fluvoxamine
(Luvox), Citalopram (Celexa), Fluoxetine (Prozac), Paroxetine
(Paxil), and Sertraline (Zoloft).
The
report offers a comprehensive evaluation of the market. It does so
via in-depth insights, understanding market evolution by tracking
historical developments, and analyzing the present scenario and
future projections based on optimistic and likely scenarios. Each
research report serves as a repository of analysis and information
for every facet of the market, including but not limited to: Regional
markets, technology developments, types, applications, and the
competitive landscape.
The
study is a source of reliable data on:
Key
market segments and sub-segments
Evolving
market trends and dynamics
Changing
supply and demand scenarios
Quantifying
market opportunities through market sizing and market forecasting
Tracking
current trends/opportunities/challenges
Competitive
insights
Opportunity
mapping in terms of technological break throughs
The
regional analysis covers:
North
America (U.S. and Canada)
Latin
America (Mexico, Brazil, Peru, Chile, and others)
Western
Europe (Germany, U.K., France, Spain, Italy, Nordic countries,
Belgium, Netherlands, Luxembourg)
Eastern
Europe (Poland, Russia)
Asia
Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
Middle
East and Africa (GCC, Southern Africa, North Africa)
Send
An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1357480
TMR
estimates the market size of various sectors using a combination of
available data on the number and revenue of companies within each
sub-sector and tiers of companies. The basic components used to
determine market size and forecast for a specific product area are
not only limited to supply-side data, but are also related to demand,
industry trends, and the economic outlook. All the above data points
are utilized to generate a statistical model targeting the sector
marketplace. More than 300 TMR analysts across the world integrate
these elements into a framework to determine the subsector market
size for a base year and then forecast growth within each market.
TMR
regularly interviews technology and business professionals as an
ongoing effort to track the latest developments within each sector.
These continuous surveys are stratified by company size and industry
segment and weighted to reflect the global market place. All data
are collected on an ongoing effort through a structured questionnaire
rolled over the web or conducted via telephones. This provides the
TMR team opportunities to request for detailed question sets, complex
skip patterns, and real-time calculations, which assists respondents
in answering questions involving numbers and percentages.
Respondents, who are interviewed as experts, are screened and
qualified based on certain criteria in addition to their
decision-making authority and the scope of activity within their
organizations.
Check
Discount This Report From Here @
https://www.marketresearchreports.biz/sample/checkdiscount/1357480
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment